Lorviqua Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

25 mg: 8 mm round tan immediate release film-coated tablet, debossed with "Pfizer" on one side and "25" and "LLN" on the other side.
Each 25 mg film-coated tablet contains 25 mg of lorlatinib.
100 mg: oval (8.5 × 17 mm) lavender immediate release film-coated tablet, debossed with "Pfizer" on one side and "LLN 100" on the other side.
Each 100 mg film-coated tablet contains 100 mg of lorlatinib.
Excipients/Inactive Ingredients: Tablet core contains: Microcrystalline Cellulose, Dibasic Calcium Phosphate Anhydrous, Sodium Starch Glycolate, Magnesium Stearate.
Film-coating contains: HPMC 2910/Hypromellose, Lactose Monohydrate, Macrogol 4000/PEG 3350, Triacetin, Titanium Dioxide, Ferrosoferric Oxide/Black Iron Oxide, Iron Oxide Red.

lorlatinib

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma